RS Investment Management’s Integra LifeSciences IART Stock Holding History

RS Investment Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$56.6M	Buy	+1,419,006	New	+$51.1M	0.58%	39

Other funds holding IART

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

RS Investment Management's IART Position: Q2 2016 in Review

RS Investment Management opened a new position in Integra LifeSciences (IART) in Q2 2016: 1,419,006 shares worth $56.6M. The stake represents 0.58% of the portfolio and ranks #39 among its holdings.

211 funds tracked by Wall St. Rank hold IART as of Q2 2016.

RS Investment Management held 1,419,006 shares of Integra LifeSciences worth $56.6M as of Q2 2016.
Integra LifeSciences was a new RS Investment Management position in Q2 2016.
Integra LifeSciences made up 0.58% of RS Investment Management's portfolio in Q2 2016, its #39 holding.
211 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.